| Bioactivity | GSK3β-IN-1 (compound 1) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=65 nM), which can be used in the study of Alzheimer's disease[1]. |
| CAS | 757198-76-8 |
| Formula | C17H13FN2O4S |
| Molar Mass | 360.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Saitoh M, et al. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta. Bioorg Med Chem. 2009 Mar 1;17(5):2017-29. |
GSK3β-IN-1
CAS: 757198-76-8 F: C17H13FN2O4S W: 360.36
GSK3β-IN-1 (compound 1) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=65 nM), which can be used in the st
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.